Health & Fitness
Fri, June 1, 2012Thu, May 31, 2012Wed, May 30, 2012Tue, May 29, 2012Mon, May 28, 2012Sun, May 27, 2012Sat, May 26, 2012Fri, May 25, 2012Thu, May 24, 2012Wed, May 23, 2012Tue, May 22, 2012Mon, May 21, 2012Sun, May 20, 2012Sat, May 19, 2012Fri, May 18, 2012Today's Economic Outlook - Report Highlights Amylin Pharmaceuticals, Inc. and Wal-Mart Stores, Inc.
//health-fitness.news-articles.net/content/2012/ .. pharmaceuticals-inc-and-wal-mart-stores-inc.html
Published in Health and Fitness on Friday, May 25th 2012 at 6:10 GMT by Market Wire🞛 This publication is a summary or evaluation of another publication
May 25, 2012 09:00 ET
Today's Economic Outlook - Report Highlights Amylin Pharmaceuticals, Inc. and Wal-Mart Stores, Inc.
HONG KONG--(Marketwire - May 25, 2012) - Today, [ www.BrightonMarkets.com ] announced new reports highlighting Amylin Pharmaceuticals, Inc. (
Economic fundamentals leading into 2012 have set a generally positive pace with GDP growth likely to pick up through the coming year. However, there are several important caveats to note as the world economy continues to face headwinds and risks weigh to the downside. Positive outlooks are conditional on fiscal policy in payroll taxes and unemployment insurance benefits and upon the easing of the European debt situation. A repeat of volatility experience in 2011 is likely in 2012, as perceptions about the strength of the U.S. economy and the euro zone will vary over time as events unfold.
Despite the current situation, our team continues to identify high momentum situations with growth potential -- there remains strong opportunity within careful discretion.
Brighton Markets is releasing new coverage on Amylin Pharmaceuticals, Inc. for its current position within the healthcare industry. Amylin Pharmaceuticals, Inc. (Amylin) is a biopharmaceutical company focusing on the diabetes and other metabolic diseases through the discovery, development and commercialization of medicines. The Company is marketing two medicines to treat diabetes, BYETTA (exenatide) injection and SYMLIN (pramlintide acetate) injection. The full research report on Amylin Pharmaceuticals, Inc. (
Brighton Markets has released research on Wal-Mart Stores, Inc. for its changing role within the services industry. Wal-Mart Stores, Inc. (Walmart) operates retail stores in various formats around globally. Everyday low prices (EDLP) is the Company's pricing philosophy under, which it price items at a low price everyday. The Company's operates in three business segments: the Walmart U.S. segment, the Walmart International segment, and the Sam's Club segment. The full research report on Wal-Mart Stores, Inc. (
About Brighton Markets
Brighton Markets was founded on the guiding principle of providing highly relevant, meaningful, and actionable information direct to investors. Across the investment spectrum, Brighton Markets shines light on today's events.
